Durable audit route for one claim-like target. This page shows source-use records, assessment rationale, active challenges, revisions, and graph edges tied to the same target identity.
Rare liver injury signals is included with provisional confidence because the record has direct section evidence but still needs endpoint-specific interpretation before it should be read as a strong clinical claim.
The assessment is anchored to the cited clinical guidance record rather than inferred from the compound name alone.
Sources considered for this assessment[1]
The row has an explicit structured record and citation mapping.
The current seed evidence does not yet carry the same detailed endpoint interpretation as Taurine.
The audit path is present; additional source interpretation can be added without changing the schema.
Rare liver injury signals are represented as a watch-list concern for botanical-extract schema coverage.
This source supports safety, monitoring, or interaction context for the safety profile.